GRIN2B antibody (C-Term)
Quick Overview for GRIN2B antibody (C-Term) (ABIN8072455)
Target
See all GRIN2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- C-Term
-
Purpose
- NMDAR2B Mouse Monoclonal Antibody
-
Predicted Reactivity
- Pig,Bovine,Horse,Rabbit,Dog,Xenopus
-
Purification
- Affinity-chromatography.
-
Immunogen
- A synthesized peptide derived from human NMDAR2B, corresponding to a region within C-terminal amino acids.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- WB 1:500-1:3000, IHC 1:50-1:200, IF/ICC 1:100-1:500
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Mouse IgG1 in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C. Stable for 12 months from date of receipt.
-
Expiry Date
- 12 months
-
-
- GRIN2B (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2B (GRIN2B))
-
Alternative Name
- NMDAR2B
-
UniProt
- Q13224
-
Pathways
- Response to Growth Hormone Stimulus, Synaptic Membrane, Feeding Behaviour, Regulation of long-term Neuronal Synaptic Plasticity
Target
-